PHARMAC's updated guidelines for cost-effectiveness analyses, with new discount rate.
Grocott
Rachel
R
Metcalfe
Scott
S
D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D017408:Guidelines as Topic; D006801:Humans; D009520:New Zealand